Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy

Yumie Rhee, Jong Doo Lee, Kyoo Ho Shin, Hyun Chul Lee, Kap Bum Huh, Sung Kil Lim

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

In a 40-year-old man who had suffered from vague and generalized bone pains for 7 years due to oncogenic osteomalacia, the causative tumour was finally detected by Indium-111 octreotide scintigraphy. Some characteristics of the tumour associated with oncogenic osteomalacia, such as its size, growth rate, location and origin, often make the diagnosis difficult. However, the recent discovery of somatostatin receptors in mesenchymal tumours, which are the most common cause of oncogenic osteomalacia, has raised the possibility of early detection of this devastating disorder. Here, we report that radiolabelled octreotide scintigraphy has a potential role as a diagnostic tool in oncogenic osteomalacia. However, the exact role of somatostatin receptors in tumours associated with oncogenic osteomalacia still remains elusive.

Original languageEnglish
Pages (from-to)551-554
Number of pages4
JournalClinical Endocrinology
Volume54
Issue number4
DOIs
Publication statusPublished - 2001 Dec 1

Fingerprint

Radionuclide Imaging
Somatostatin Receptors
Neoplasms
Octreotide
indium-111-octreotide
Oncogenic osteomalacia
Bone and Bones
Pain
Growth

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Rhee, Yumie ; Lee, Jong Doo ; Shin, Kyoo Ho ; Lee, Hyun Chul ; Huh, Kap Bum ; Lim, Sung Kil. / Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. In: Clinical Endocrinology. 2001 ; Vol. 54, No. 4. pp. 551-554.
@article{71ade6b40e7c4fe6a8d8be265a5c4495,
title = "Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy",
abstract = "In a 40-year-old man who had suffered from vague and generalized bone pains for 7 years due to oncogenic osteomalacia, the causative tumour was finally detected by Indium-111 octreotide scintigraphy. Some characteristics of the tumour associated with oncogenic osteomalacia, such as its size, growth rate, location and origin, often make the diagnosis difficult. However, the recent discovery of somatostatin receptors in mesenchymal tumours, which are the most common cause of oncogenic osteomalacia, has raised the possibility of early detection of this devastating disorder. Here, we report that radiolabelled octreotide scintigraphy has a potential role as a diagnostic tool in oncogenic osteomalacia. However, the exact role of somatostatin receptors in tumours associated with oncogenic osteomalacia still remains elusive.",
author = "Yumie Rhee and Lee, {Jong Doo} and Shin, {Kyoo Ho} and Lee, {Hyun Chul} and Huh, {Kap Bum} and Lim, {Sung Kil}",
year = "2001",
month = "12",
day = "1",
doi = "10.1046/j.1365-2265.2001.01056.x",
language = "English",
volume = "54",
pages = "551--554",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "4",

}

Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. / Rhee, Yumie; Lee, Jong Doo; Shin, Kyoo Ho; Lee, Hyun Chul; Huh, Kap Bum; Lim, Sung Kil.

In: Clinical Endocrinology, Vol. 54, No. 4, 01.12.2001, p. 551-554.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy

AU - Rhee, Yumie

AU - Lee, Jong Doo

AU - Shin, Kyoo Ho

AU - Lee, Hyun Chul

AU - Huh, Kap Bum

AU - Lim, Sung Kil

PY - 2001/12/1

Y1 - 2001/12/1

N2 - In a 40-year-old man who had suffered from vague and generalized bone pains for 7 years due to oncogenic osteomalacia, the causative tumour was finally detected by Indium-111 octreotide scintigraphy. Some characteristics of the tumour associated with oncogenic osteomalacia, such as its size, growth rate, location and origin, often make the diagnosis difficult. However, the recent discovery of somatostatin receptors in mesenchymal tumours, which are the most common cause of oncogenic osteomalacia, has raised the possibility of early detection of this devastating disorder. Here, we report that radiolabelled octreotide scintigraphy has a potential role as a diagnostic tool in oncogenic osteomalacia. However, the exact role of somatostatin receptors in tumours associated with oncogenic osteomalacia still remains elusive.

AB - In a 40-year-old man who had suffered from vague and generalized bone pains for 7 years due to oncogenic osteomalacia, the causative tumour was finally detected by Indium-111 octreotide scintigraphy. Some characteristics of the tumour associated with oncogenic osteomalacia, such as its size, growth rate, location and origin, often make the diagnosis difficult. However, the recent discovery of somatostatin receptors in mesenchymal tumours, which are the most common cause of oncogenic osteomalacia, has raised the possibility of early detection of this devastating disorder. Here, we report that radiolabelled octreotide scintigraphy has a potential role as a diagnostic tool in oncogenic osteomalacia. However, the exact role of somatostatin receptors in tumours associated with oncogenic osteomalacia still remains elusive.

UR - http://www.scopus.com/inward/record.url?scp=0035725603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035725603&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2265.2001.01056.x

DO - 10.1046/j.1365-2265.2001.01056.x

M3 - Article

C2 - 11318793

AN - SCOPUS:0035725603

VL - 54

SP - 551

EP - 554

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 4

ER -